BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 35879779)

  • 1. A multiscale brain network model links Alzheimer's disease-mediated neuronal hyperactivity to large-scale oscillatory slowing.
    van Nifterick AM; Gouw AA; van Kesteren RE; Scheltens P; Stam CJ; de Haan W
    Alzheimers Res Ther; 2022 Jul; 14(1):101. PubMed ID: 35879779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oscillatory Activity of the Hippocampus in Prodromal Alzheimer's Disease: A Source-Space Magnetoencephalography Study.
    Luppi JJ; Schoonhoven DN; van Nifterick AM; Gouw AA; Hillebrand A; Scheltens P; Stam CJ; de Haan W
    J Alzheimers Dis; 2022; 87(1):317-333. PubMed ID: 35311705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altering neuronal excitability to preserve network connectivity in a computational model of Alzheimer's disease.
    de Haan W; van Straaten ECW; Gouw AA; Stam CJ
    PLoS Comput Biol; 2017 Sep; 13(9):e1005707. PubMed ID: 28938009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired long-range excitatory time scale predicts abnormal neural oscillations and cognitive deficits in Alzheimer's disease.
    Verma P; Ranasinghe K; Prasad J; Cai C; Xie X; Lerner H; Mizuiri D; Miller B; Rankin K; Vossel K; Cheung SW; Nagarajan SS; Raj A
    Alzheimers Res Ther; 2024 Mar; 16(1):62. PubMed ID: 38504361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal synchrony abnormalities associated with subclinical epileptiform activity in early-onset Alzheimer's disease.
    Ranasinghe KG; Kudo K; Hinkley L; Beagle A; Lerner H; Mizuiri D; Findlay A; Miller BL; Kramer JH; Gorno-Tempini ML; Rabinovici GD; Rankin KP; Garcia PA; Kirsch HE; Vossel K; Nagarajan SS
    Brain; 2022 Apr; 145(2):744-753. PubMed ID: 34919638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the contributions to hyperexcitability in a mouse model of Alzheimer's disease.
    Mittag M; Mediavilla L; Remy S; Cuntz H; Jedlicka P
    J Physiol; 2023 Aug; 601(15):3403-3437. PubMed ID: 36734280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the fluctuations of dynamic resting-state electrophysiological functional connectivity: reduced neuronal coupling variability in mild cognitive impairment and dementia due to Alzheimer's disease.
    Núñez P; Poza J; Gómez C; Rodríguez-González V; Hillebrand A; Tola-Arribas MA; Cano M; Hornero R
    J Neural Eng; 2019 Sep; 16(5):056030. PubMed ID: 31112938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer's disease.
    Wiesman AI; Murman DL; Losh RA; Schantell M; Christopher-Hayes NJ; Johnson HJ; Willett MP; Wolfson SL; Losh KL; Johnson CM; May PE; Wilson TW
    Brain; 2022 Jun; 145(6):2177-2189. PubMed ID: 35088842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity dependent degeneration explains hub vulnerability in Alzheimer's disease.
    de Haan W; Mott K; van Straaten EC; Scheltens P; Stam CJ
    PLoS Comput Biol; 2012; 8(8):e1002582. PubMed ID: 22915996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal gamma phase-amplitude coupling in the parahippocampal cortex is associated with network hyperexcitability in Alzheimer's disease.
    Prabhu P; Morise H; Kudo K; Beagle A; Mizuiri D; Syed F; Kotegar KA; Findlay A; Miller BL; Kramer JH; Rankin KP; Garcia PA; Kirsch HE; Vossel K; Nagarajan SS; Ranasinghe KG
    Brain Commun; 2024; 6(2):fcae121. PubMed ID: 38665964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha rhythm slowing in a modified thalamo-cortico-thalamic model related with Alzheimer's disease.
    Li X; Yang X; Sun Z
    PLoS One; 2020; 15(3):e0229950. PubMed ID: 32163454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short timescale abnormalities in the states of spontaneous synchrony in the functional neural networks in Alzheimer's disease.
    Sitnikova TA; Hughes JW; Ahlfors SP; Woolrich MW; Salat DH
    Neuroimage Clin; 2018; 20():128-152. PubMed ID: 30094163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual neural network-guided optimization of non-invasive brain stimulation in Alzheimer's disease.
    Luppi JJ; Stam CJ; Scheltens P; de Haan W
    PLoS Comput Biol; 2024 Jan; 20(1):e1011164. PubMed ID: 38232116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking Molecular Pathways and Large-Scale Computational Modeling to Assess Candidate Disease Mechanisms and Pharmacodynamics in Alzheimer's Disease.
    Stefanovski L; Triebkorn P; Spiegler A; Diaz-Cortes MA; Solodkin A; Jirsa V; McIntosh AR; Ritter P;
    Front Comput Neurosci; 2019; 13():54. PubMed ID: 31456676
    [No Abstract]   [Full Text] [Related]  

  • 15. Spatio-Temporal Fluctuations of Neural Dynamics in Mild Cognitive Impairment and Alzheimer's Disease.
    Poza J; Gómez C; García M; Tola-Arribas MA; Carreres A; Cano M; Hornero R
    Curr Alzheimer Res; 2017; 14(9):924-936. PubMed ID: 28290246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha band disruption in the AD-continuum starts in the Subjective Cognitive Decline stage: a MEG study.
    López-Sanz D; Bruña R; Garcés P; Camara C; Serrano N; Rodríguez-Rojo IC; Delgado ML; Montenegro M; López-Higes R; Yus M; Maestú F
    Sci Rep; 2016 Nov; 6():37685. PubMed ID: 27883082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEG Oscillatory Slowing in Cognitive Impairment is Associated with the Presence of Subjective Cognitive Decline.
    Bruña R; López-Sanz D; Maestú F; Cohen AD; Bagic A; Huppert T; Kim T; Roush RE; Snitz B; Becker JT
    Clin EEG Neurosci; 2023 Jan; 54(1):73-81. PubMed ID: 35188831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatiotemporal Oscillatory Patterns During Working Memory Maintenance in Mild Cognitive Impairment and Subjective Cognitive Decline.
    Serrano N; López-Sanz D; Bruña R; Garcés P; Rodríguez-Rojo IC; Marcos A; Crespo DP; Maestú F
    Int J Neural Syst; 2020 Jan; 30(1):1950019. PubMed ID: 31522594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Magnetoencephalography in the Early Stages of Alzheimer Disease.
    Maestú F; Fernández A
    Neuroimaging Clin N Am; 2020 May; 30(2):217-227. PubMed ID: 32336408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.